Real-time enrollment status for this solid tumor clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:55 AM UTC
| NCT Number | NCT05244551 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor |
| Phase | Clinical Trial |
| Target Enrollment | 85 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abbisko Therapeutics Co, Ltd |
| Last Updated on CT.gov | August 12, 2024 (Aug 12, 2024) |
As of July 13, 2026: Clinical trial NCT05244551 is currently recruiting participants. This clinical trial study for solid tumor is actively seeking new participants at 1 location across the United States. The study is sponsored by Abbisko Therapeutics Co, Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05244551 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05244551 was last updated Aug 12, 2024 (August 12, 2024). HelloStudys verifies this status automatically.